Tandem integrates Dexcom G7 into insulin pumps, Medtronic wins CE mark for neurostim tech

Fast Five Medtech News Podcast

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, Dec. 7, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Merit Medical upsized a private placement to $650 million and could bring in as much as $725 million from the offering. Fast Five hosts Jim Hammerand and Sean Whooley look at the details of the offering, as well as Merit's potential plans with the proceeds. The hosts look at a major reimbursement win for Ambu, breaking down some of the features of the company's single-use bronchoscope technology and why CMS decided to allow incremental reimbursement for outpatient procedures. Levita Magnetics announced the completion of the first procedures outside the U.S. with its surgical robotic technology. Hear all about the magnetic-based MARS platform, the surgeries that took place in South America and what this milestone means to Levita's CEO. Medtronic earned CE mark for the latest device in its Precept family of deep brain stimulation implants. While it remains investigational in the U.S., the hosts look at what this implant brings to the European market as a first-of-its-kind offering. In a milestone announcement for diabetes technology, Tandem Diabetes Care and Dexcom say they launched an integrated artificial pancreas system using Tandem's pump technology and Dexcom's next-generation G7 CGM. Whooley and Hammerand explain the significance of this integration and the benefits for users of the technology.